We are live on
!
Find out more
SCM
Stevens Capital Management Portfolio holdings
AUM
$417M
1-Year Est. Return
54.95%
This Fund
S&P 500
This Quarter
Est. Return
+2.44%
1 Year Est. Return
+54.95%
3 Year Est. Return
+108.43%
5 Year Est. Return
+127.3%
10 Year Est. Return
+330.23%
AUM
$2.24B
AUM Growth
-$107M
(-4.6%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-6.17%
Top 10 Holdings %
Top 10 Hldgs %
13.17%
Holding
955
New
308
Increased
134
Reduced
160
Closed
350
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.3M |
| 2 |
Merck
MRK
|
+$28.9M |
| 3 |
Morgan Stanley
MS
|
+$28.2M |
| 4 |
Verizon
VZ
|
+$27.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$22.4M |
| 2 |
Duke Energy
DUK
|
+$22M |
| 3 |
Cognizant
CTSH
|
+$19.2M |
| 4 |
Fidelity National Information Services
FIS
|
+$19M |
| 5 |
Eaton
ETN
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.41% |
| 2 | Healthcare | 15.37% |
| 3 | Industrials | 13.25% |
| 4 | Technology | 12.54% |
| 5 | Consumer Staples | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cisco
CSCO
$430B
| $30.4M | 1.36% |
555,338
+156,143
| +39% | +$8.62M |
|
|
2
Eli Lilly
LLY
$1T
| $30.3M | 1.35% |
273,389
+265,899
| +3,550% | +$31.3M |
|
3
Berkshire Hathaway Class B
BRK.B
$1.08T
| $30.2M | 1.35% |
141,762
-8,474
| -6% | -$1.75M |
|
|
4
Merck
MRK
$366B
| $30.2M | 1.35% |
+377,581
| New | +$28.9M |
|
5
Procter & Gamble
PG
$338B
| $30.2M | 1.35% |
275,344
-8,166
| -3% | -$870K |
|
|
6
Johnson & Johnson
JNJ
$649B
| $30.2M | 1.35% |
216,724
+172,097
| +386% | +$23.8M |
|
7
Honeywell
HON
$66B
| $30.1M | 1.35% |
183,002
+98,452
| +116% | +$15.7M |
|
8
Ford
F
$55.9B
| $27.8M | 1.24% |
2,716,129
+489,912
| +22% | +$4.83M |
|
|
9
Morgan Stanley
MS
$340B
| $27.7M | 1.24% |
+632,774
| New | +$28.2M |
|
|
10
Verizon
VZ
$209B
| $27.4M | 1.22% |
+478,928
| New | +$27.6M |
|
11
VanEck Gold Miners ETF
GDX
$29.9B
| $27.2M | 1.22% |
+1,064,414
| New | +$23.5M |
|
12
Simon Property Group
SPG
$68.6B
| $25.8M | 1.15% |
161,241
+62,370
| +63% | +$10.7M |
|
13
Colgate-Palmolive
CL
$70.5B
| $25.3M | 1.13% |
352,861
+179,465
| +104% | +$12.7M |
|
14
Progressive
PGR
$125B
| $24.7M | 1.11% |
309,185
+97,133
| +46% | +$7.51M |
|
15
AbbVie
ABBV
$440B
| $24.3M | 1.09% |
334,347
+12,289
| +4% | +$966K |
|
16
CVS Health
CVS
$123B
| $24.2M | 1.08% |
444,179
+231,718
| +109% | +$12.5M |
|
17
PayPal
PYPL
$45.5B
| $24.2M | 1.08% |
+211,355
| New | +$23.4M |
|
18
Walmart Inc
WMT
$842B
| $23.7M | 1.06% |
644,232
-281,595
| -30% | -$9.7M |
|
19
Nike
NKE
$56.5B
| $23.7M | 1.06% |
+282,502
| New | +$23.8M |
|
20
Microsoft
MSFT
$3.67T
| $23.5M | 1.05% |
175,166
-6,080
| -3% | -$772K |
|
21
Amazon
AMZN
$2.77T
| $23M | 1.03% |
243,180
-64,980
| -21% | -$6.05M |
|
22
Alphabet (Google) Class C
GOOG
$4.1T
| $21.3M | 0.95% |
394,940
+139,320
| +55% | +$8.04M |
|
23
Exelon
EXC
$45.3B
| $21.2M | 0.95% |
+620,192
| New | +$21.9M |
|
24
Medtronic
MDT
$118B
| $20.9M | 0.94% |
214,951
-115,621
| -35% | -$10.6M |
|
25
Oracle
ORCL
$468B
| $19.5M | 0.87% |
+342,961
| New | +$18.6M |
|
Similar funds
AP
MWM
RWM
RSS
EWM
SCM
CWA
AC
Stevens Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Stevens Capital Management held 955 positions worth $2.24B, down 4.6% from $2.34B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Stevens Capital Management withdrew a net $138M in Q2 2019, closing 350 positions and reducing 160 holdings. Its most notable exit was Cognizant, an estimated $19.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Stevens Capital Management opened a new position in Merck worth $30.2M.
- Stevens Capital Management's largest Q2 2019 buy was Merck: 377,581 shares worth $30.2M.
- Stevens Capital Management added most to Eli Lilly in Q2 2019, an estimated $31.3M increase.
- Stevens Capital Management's biggest Q2 2019 reduction was CME Group, cutting an estimated $22.4M.
- Stevens Capital Management fully exited Cognizant in Q2 2019, selling an estimated $19.2M.
- Stevens Capital Management's ten largest holdings make up 13% of its $2.24B portfolio in Q2 2019.
- Stevens Capital Management opened 308 new positions and closed 350 in Q2 2019.
- Stevens Capital Management's portfolio value fell 4.6% quarter-over-quarter to $2.24B.
Based on Stevens Capital Management's 13F filing for Q2 2019, filed 31 Jul 2019.